We studied the differential response to SAHA in lung cancer cells with oncogenic activation of MYC (hereafter referred to as MYCamp) with respect to those with genetic inactivation of SMARCA4 (hereafter, SMARCA4def). This evidence concerns the gene MYC and lung cancer.